Event Overview
To the casual observer, Sampling Plans can be incredible complex and hard to apply. Worse yet, the subject is a jungle with non-intuitive jargon and crazy acronyms. So why bother?
- The key advantage is that Sampling Plans can save time, money and resources. It certainly answers the question: “How much is enough?”
- Sampling plans help decision makers understand the risk involved in accepting a product or process.
- Well-designed training can cut through the jungle and provide a clear pathway.
This workshop provides a set of simple-to-follow procedures that will keep-it-simple to apply. A wide variety of industry applications will motivate the subject. While the terminology and acronyms used are “industry standard”, participants will not be burdened with statistical complexity. Participants do not need any background in statistics.
For FDA-regulated companies, sampling is a key statistical method used for Design Control, Process Validation, CAPA, Complaint Monitoring, and for Receiving, In-Process, & Finished Device Acceptance. We will discuss the recommendations of the guidance documents developed by the FDA and the Global Harmonization Task Force (GHTF) along with industry standards.
There are two interactive webinars in this workshop. Each webinar is two hours.
- Acceptance Sampling Plans for Variable Inspections | November 16, 2022 | 1:00-3:00pm Eastern
- Acceptance Sampling Plans for Inspection by Attribute | November 17, 2022 | 1:00-3:00pm Eastern
For more information: https://us-tdm-tso-15eb63ff4c6-1626e-169df4b0a12.force.com/s/lt-event?id=a1Y2E000009UKXY